• 2022/08/04 ir Consolidated Financial Results for the Three Months Ended June 30, 2022 (Under Japanese GAAP) pdf (394KB)

  • 2022/07/22 withLink Launched a CDMO service using CereAAV™, a brain-tropic AAV vector for gene therapy

    読む Launched a CDMO service using CereAAV™, a brain-tropic AAV vector for gene therapy

  • 2022/07/06 ir [Delayed] Corporate Governance Report pdf (770KB)

  • 2022/06/13 ir Notice of the 20th Annual General Meeting of Shareholders pdf (208KB)

  • 2022/06/01 withLink Takara Bio to Present Clinical Data from Investigator-Initiated Trial in Canada of NY-ESO-1・siTCR™ Gene Therapy at ASCO2022 【Poster Posted】

    読む Takara Bio to Present Clinical Data from Investigator-Initiated Trial in Canada of NY-ESO-1・siTCR™ Gene Therapy at ASCO2022 【Poster Posted】

全てのニュース